EPIEN Medical, Inc. (EPMI)
EPIEN Medical was planning to go public, but the IPO was withdrawn on Mar 21, 2023.
IPO Price Range
$4.25 - $6.25
Shares Offered
4,190,476
Deal Size
$22.00M
EPIEN Medical Statistics
Total Valuation
EPIEN Medical has a market cap or net worth of $74.13 million. The enterprise value is $81.87 million.
| Market Cap | 74.13M |
| Enterprise Value | 81.87M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
EPIEN Medical has 14.12 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 14.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.24 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 64.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.30 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $97,908 |
| Profits Per Employee | -$292,186 |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPIEN Medical had revenue of $1.27 million and -$3.80 million in losses. Loss per share was -$0.27.
| Revenue | 1.27M |
| Gross Profit | 964,963 |
| Operating Income | -2.64M |
| Pretax Income | -3.80M |
| Net Income | -3.80M |
| EBITDA | -2.51M |
| EBIT | -2.65M |
| Loss Per Share | -$0.27 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 7.75M |
| Net Cash | -7.75M |
| Net Cash Per Share | -$0.55 |
| Equity (Book Value) | -14.32M |
| Book Value Per Share | -1.01 |
| Working Capital | -11.96M |
Cash Flow
In the last 12 months, operating cash flow was -$2.14 million and capital expenditures -$61,121, giving a free cash flow of -$2.20 million.
| Operating Cash Flow | -2.14M |
| Capital Expenditures | -61,121 |
| Free Cash Flow | -2.20M |
| FCF Per Share | -$0.16 |
Margins
Gross margin is 75.81%, with operating and profit margins of -207.34% and -298.43%.
| Gross Margin | 75.81% |
| Operating Margin | -207.34% |
| Pretax Margin | -298.43% |
| Profit Margin | -298.43% |
| EBITDA Margin | -197.34% |
| EBIT Margin | -208.02% |
| FCF Margin | -173.23% |
Dividends & Yields
EPIEN Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -5.12% |
| FCF Yield | -2.97% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |